Hello,

We noticed you're browsing in private or incognito mode.

To continue reading this article, please exit incognito mode or log in.

Not an Insider? Subscribe now for unlimited access to online articles.

Rewriting Life

Treating Breast Cancer with Heat

Microwaves can significantly shrink cancer cells.

Heating breast-cancer cells with focused beams of microwave energy after chemotherapy can significantly shrink and kill tumors, according to results from a new clinical trial. The treatment increases blood flow into tumors, allowing chemotherapy drugs to more easily invade cancer cells. In patients who received both the heat treatment, known as thermotherapy, and chemotherapy, tumors showed 50 percent more shrinkage than tumors that strictly received chemotherapy, allowing the majority of patients to avoid mastectomy.

Raising the temperature: A focused microwave system developed at MIT can shrink breast tumors by heating them. The delivery system, shown here, is approximately six feet long by three feet wide and three to four feet tall. While the patient lies in the prone position on the table, the treated breast is suspended through a hole in the table and gently compressed. Two focused microwave antennae on either side of the breast heat the tumor.

“In part, we are killing the cancer cells with heat, and we are also making the chemotherapy drug more effective by increasing blood flow to tumors that typically have poor vasculature,” says Alan J. Fenn, a senior staff member at the Lincoln Laboratory at MIT, who originally developed the technology. The technique is similar to the idea of radiation therapy but with fewer side effects. “Radiation therapy blankets the entire breast, and what we are trying to do is heat cancer cells in a large region of the breast to kill them,” says Fenn.

Previous studies of Fenn’s thermotherapy showed that it could shrink small to large tumors. In the newest study, published online last week in the journal Cancer Therapy, researchers aimed to use the microwave treatment in combination with chemotherapy to shrink tumors enough to allow patients to undergo lumpectomy–breast-conserving surgery–rather than radical mastectomy, or removal of the breast.

Fifteen of 28 patients received two cycles of chemotherapy, followed a few hours later by thermotherapy, in which a 915-megahertz microwave was focused on the tumor, raising its temperature to 108 ºF. After the combined treatments, 14 of the patients’ tumors decreased enough for lumpectomy: the volume of the tumor shrank by about 88 percent, compared with 59 percent in patients who received chemotherapy alone. The trials were conducted at UCLA Medical Center, in Torrance, CA; the University of Oklahoma Health Science Center, in Oklahoma City, OK; the Comprehensive Breast Center, in Coral Springs, FL; and St. Joseph’s Hospital, in Orange County, CA.

There are minimal treatment options for patients with tumors deep in the breast or with large tumors in the intact breast, says Paul Stauffer, a professor and director of hyperthermia physics in the radiation oncology department at Duke University Medical Center, in Durham, NC. “Based on the results of the trial, this may be the best approach to treat tumors in the intact breast,” he says.

The microwave technology used in the trial was originally developed at MIT as a missile-detection tool. (See “Microwave Tumors.”) Two plastic plates, one placed on either side, gently compress the breast, while microwave antennae about an inch away from the plates deliver the microwaves, preferentially targeting the high water and high ion content of the breast-cancer cells rather than the low water and low ion content of the healthy, fatty tissues. The antennae adaptively focus the microwaves at the tumor position. The energy sent through the tumor causes the water molecules to collide and generate heat through friction, eventually elevating the temperature of the tumor.

“This is a very promising future direction for breast-cancer treatment, and hopefully for other tumors as well,” says Constance D. Lehman, a professor and the vice chair of radiology at the University of Washington, and the director of radiology at the Seattle Cancer Care Alliance.

To date, about 100 patients have received the focused microwave treatment in four clinical trials. The team of researchers is now preparing for a larger clinical trial, estimated at 228 patients, to start in 2008. Fenn says that it will take about two years from the time the researchers start the study for the technology to be approved by the Federal Drug Administration.

Be the leader your company needs. Implement ethical AI.
Join us at EmTech Digital 2019.

Register now
More from Rewriting Life

Reprogramming our bodies to make us healthier.

Want more award-winning journalism? Subscribe to Insider Plus.
  • Insider Plus {! insider.prices.plus !}*

    {! insider.display.menuOptionsLabel !}

    Everything included in Insider Basic, plus the digital magazine, extensive archive, ad-free web experience, and discounts to partner offerings and MIT Technology Review events.

    See details+

    Print + Digital Magazine (6 bi-monthly issues)

    Unlimited online access including all articles, multimedia, and more

    The Download newsletter with top tech stories delivered daily to your inbox

    Technology Review PDF magazine archive, including articles, images, and covers dating back to 1899

    10% Discount to MIT Technology Review events and MIT Press

    Ad-free website experience

/3
You've read of three free articles this month. for unlimited online access. You've read of three free articles this month. for unlimited online access. This is your last free article this month. for unlimited online access. You've read all your free articles this month. for unlimited online access. You've read of three free articles this month. for more, or for unlimited online access. for two more free articles, or for unlimited online access.